Thyroid fine-needle aspiration samples inadequate for reverse transcriptase-polymerase chain reaction analysis

Cancer

Volumn 114, Issue 3, 2008, Pages 187-195

  Samija, Ivan ^a   Matesa, Neven ^a   Lukac, Josip ^a   Kusic, Zvonko ^a  

^a SESTRE MILOSRDNICE UNIVERSITY HOSPITAL   (Croatia)

Author keywords

Fine needle biopsy; Glyceraldehyde 3 phosphate dehydrogenase (phosphorylating); Reverse transcriptase polymerase chain reaction; Thyroglobulin; Thyroid neoplasms; Thyroid nodules

Indexed keywords

GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; THYROGLOBULIN; TUMOR MARKER;

ADULT; ARTICLE; ASPIRATION BIOPSY; CANCER PATIENT; CYTODIAGNOSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC PROCEDURE; FEMALE; GAPDH GENE; HOUSEKEEPING GENE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PUNCTURE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; THYROID NODULE;

BIOLOGICAL MARKERS; BIOPSY, FINE-NEEDLE; GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASES; HUMANS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; THYROGLOBULIN; THYROID GLAND; THYROID NEOPLASMS; THYROID NODULE;

EID: 47049085593     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.23498     Document Type: Article

References (52)

1. Vander JB, Gaston EA, Dawber TR. The significance of non-toxic thyroid nodules. Final report of a 15-year study of the incidence of thyroid malignancy. Ann Intern Med. 1968;69:537-540.
2. Welker MJ, Orlow D. Thyroid nodules. Am Fam Physician. 2003;67:559-566.
3. Mazzaferri EL. Thyroid cancer in thyroid nodules: finding a needle in the haystack. Am J Med. 1992;93:359-362.
4. Gharib H, Goellner JR. Fine-needle aspiration biopsy of the thyroid: an appraisal. Ann Intern Med. 1993;118:282-289.
5. Baloch ZW, LiVolsi VA. Fine-needle aspiration of thyroid nodules: past, present, and future. Endocr Pract. 2004;10:234-241.
6. Gharib H, Goellner JR, Zinsmeister AR, Grant CS, Van Heerden JA. Fine-needle aspiration biopsy of the thyroid. The problem of suspicious cytologic findings. Ann Intern Med. 1984;101:25-28.
7. Baloch ZW, Fleisher S, LiVolsi VA, Gupta PK. Diagnosis of "follicular neoplasm": a gray zone in thyroid fine-needle aspiration cytology. Diagn Cytopathol. 2002;26:41-44.
8. Castro MR, Gharib H. Continuing controversies in the management of thyroid nodules. Ann Intern Med. 2005;142:926-931.
9. Letsas KP, Andrikoula M, Tsatsoulis A. Fine needle aspiration biopsy-RT-PCR molecular analysis of thyroid nodules: a useful preoperative diagnostic tool. Minerva Endocrinol. 2006;31:179-182.
10. Bojunga J, Zeuzem S. Molecular detection of thyroid cancer: an update. Clin Endocrinol (Oxf). 2004;61:523-530.
11. Matsuo SE, Martins L, Leoni SG, et al. Biological markers in thyroid tumors. Arq Bras Endocrinol Metabol. 2004;48:114-125.
12. Bojunga J, Kusterer K, Schumm-Draeger PM, Usadel KH. Polymerase chain reaction in the detection of tumor cells: new approaches in diagnosis and follow-up of patients with thyroid cancer. Thyroid. 2002;12:1097-1107.
13. Griffith OL, Melck A, Jones SJ, Wiseman SM. Meta-analysis and meta-review of thyroid cancer gene expression profiling studies identifies important diagnostic biomarkers. J Clin Oncol. 2006;24:5043-5051.
14. Kebebew E, Peng M, Reiff E, Duh QY, Clark OH, McMillan A. Diagnostic and prognostic value of angiogenesis-modulating genes in malignant thyroid neoplasms. Surgery. 2005;138:1102-1110.
15. Lubitz CC, Ugras SK, Kazam JJ, et al. Microarray analysis of thyroid nodule fine-needle aspirates accurately classifies benign and malignant lesions. J Mol Diagn. 2006;8:490-498.
16. Kebebew E, Peng M, Reiff E, McMillan A. Diagnostic and extent of disease multigene assay for malignant thyroid neoplasms. Cancer. 2006;106:2592-2597.
17. Takano T, Sumizaki H, Amino N. Detection of CD44 variants in fine needle aspiration biopsies of thyroid tumor by RT-PCR. J Exp Clin Cancer Res. 1997;16:267-271.
18. Thellin O, Zorzi W, Lakaye B, et al. Housekeeping genes as internal standards: use and limits. J Biotechnol. 1999;75:291-295.
19. Bhatia P, Taylor WR, Greenberg AH, Wright JA. Comparison of glyceraldehyde-3-phosphate dehydrogenase and 28S-ribosomal RNA gene expression as RNA loading controls for northern blot analysis of cell lines of varying malignant potential. Anal Biochem. 1994;216:223-226.
20. Pineda PB, Rojas PG, Liberman CG, Moyano LS, Goecke IS. [Detection of malignancy markers in thyroid nodules by reverse transcriptase polymerase chain reaction (RT-PCR)] [article in Spanish]. Rev Med Chile. 2003;131:965-972.
21. Saji M, Xydas S, Westra WH, et al. Human telomerase reverse transcriptase (hTERT) gene expression in thyroid neoplasms. Clin Cancer Res. 1999;5:1483-1489.
22. Matesa N, Samija I, Kusic Z. Galectin-3 and CD44v6 positivity by RT-PCR method in fine needle aspirates of benign thyroid lesions. Cytopathology. 2007;18:112-116.
23. Takano T, Miyauchi A, Yokozawa T, et al. Accurate and objective preoperative diagnosis of thyroid papillary carcinomas by reverse transcription-PCR detection of oncofetal fibronectin messenger RNA in fine-needle aspiration biopsies. Cancer Res. 1998;58:4913-4917.
24. Umbricht CB, Conrad GT, Clark DP, et al. Human telomerase reverse transcriptase gene expression and the surgical management of suspicious thyroid tumors. Clin Cancer Res. 2004;10:5762-5768.
25. Feilchenfeldt J, Totsch M, Sheu SY, et al. Expression of galectin-3 in normal and malignant thyroid tissue by quantitative PCR and immunohistochemistry. Mod Pathol. 2003;16:1117-1123.
26. Takano T, Miyauchi A, Yokozawa T, et al. Preoperative diagnosis of thyroid papillary and anaplastic carcinomas by real-time quantitative reverse transcription-polymerase chain reaction of oncofetal fibronectin messenger RNA. Cancer Res. 1999;59:4542-4545.
27. Siddiqui MT, Greene KL, Clark DP, et al. Human telomerase reverse transcriptase expression in Diff-Quik-stained FNA samples from thyroid nodules. Diagn Mol Pathol. 2001;10:123-129.
28. World Medical Association. World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects [The World Medical association Web site]. Available at URL: http://www.wma.net/e/ policy/b3.htm Accessed November 28, 2007.
29. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 1987;162:156-159.
30. Battayani Z, Grob JJ, Xerri L, et al. Polymerase chain reaction detection of circulating melanocytes as a prognostic marker in patients with melanoma. Arch Dermatol. 1995;131:443-447.
31. Ditkoff BA, Marvin MR, Yemul S, et al. Detection of circulating thyroid cells in peripheral blood. Surgery. 1996;120:959-965.
32. Niedziela M, Maceluch J, Korman E. Galectin-3 is not an universal marker of malignancy in thyroid nodular disease in children and adolescents. J Clin Endocrinol Metab. 2002;87:4411-4415.
33. Cheung CC, Carydis B, Ezzat S, Bedard YC, Asa SL. Analysis of ret/PTC gene rearrangements refines the fine needle aspiration diagnosis of thyroid cancer. J Clin Endocrinol Metab. 2001;86:2187-2190.
34. Sequeira MJ, Morgan JM, Fuhrer D, Wheeler MH, Jasani B, Ludgate M. Thyroid transcription factor-2 gene expression in benign and malignant thyroid lesions. Thyroid. 2001;11:995-1001.
35. Domingues R, Mendonca E, Sobrinho L, Bugalho MJ. Searching for RET/PTC rearrangements and BRAF V599E mutation in thyroid aspirates might contribute to establish a preoperative diagnosis of papillary thyroid carcinoma. Cytopathology. 2005;16:27-31.
36. Giannini R, Faviana P, Cavinato T, et al. Galectin-3 and oncofetal-fibronectin expression in thyroid neoplasia as assessed by reverse transcription-polymerase chain reaction and immunochemistry in cytologic and pathologic specimens. Thyroid. 2003;13:765-770.
37. Takano T, Miyauchi A, Matsuzuka F, et al. Preoperative diagnosis of medullary thyroid carcinoma by RT-PCR using RNA extracted from leftover cells within a needle used for fine needle aspiration biopsy. J Clin Endocrinol Metab. 1999;84:951-955.
38. Karger S, Engelhardt C, Eszlinger M, et al. Cytology and mRNA expression analysis of fine needle aspirates of thyroid nodules in an East Germern region with borderline iodine deficiency. Horm Metab Res. 2006;38:662-667.
39. Arturi F, Russo D, Giuffrida D, et al. Early diagnosis by genetic analysis of differentiated thyroid cancer metastases in small lymph nodes. J Clin Endocrinol Metab. 1997;82:1638-1641.
40. Weiss M, Baruch A, Keydar I, Wreschner DH. Preoperative diagnosis of thyroid papillary carcinoma by reverse transcriptase polymerase chain reaction of the MUC1 gene. Int J Cancer. 1996;66:55-59.
41. Winzer R, Schmutzler C, Jakobs TC, et al. Reverse transcriptase- polymerase chain reaction analysis of thyrocyte-relevant genes in fine-needle aspiration biopsies of the human thyroid. Thyroid. 1998;8:981-987.
42. Takano T, Shiba E, Tada H, et al. Preoperative diagnosis of thyroid carcinomas by aspiration biopsy-reverse transcription-polymerase chain reaction (ABRP): a report of 2 cases. Endocr J. 2000;47:271-275.
43. Bugalho MJ, Mendonca E, Sobrinho LG. Medullary thyroid carcinoma: an accurate pre-operative diagnosis by reverse transcription-PCR. Eur J Endocrinol. 2000;143:335-338.
44. Chiappetta G, Tallini G, De Biasio MC, et al. FRA-1 expression in hyperplastic and neoplastic thyroid diseases. Clin Cancer Res. 2000;6:4300-4306.
45. Chiappetta G, Tallini G, De Biasio MC, et al. Detection of high mobility group I HMGI(Y) protein in the diagnosis of thyroid tumors: HMGI(Y) expression represents a potential diagnostic indicator of carcinoma. Cancer Res. 1998;58:4193-4198.
46. Zeiger MA, Smallridge RC, Clark DP, et al. Human telomerase reverse transcriptase (hTERT) gene expression in FNA samples from thyroid neoplasms. Surgery. 1999;126:1195-1198.
47. Liou MJ, Chan EC, Lin JD, Liu FH, Chao TC. Human telomerase reverse transcriptase (hTERT) gene expression in FNA samples from thyroid neoplasms. Cancer Lett. 2003;191:223-227.
48. Salvatore G, Giannini R, Faviana P, et al. Analysis of BRAF point mutation and RET/PTC rearrangement refines the fine-needle aspiration diagnosis of papillary thyroid carcinoma. J Clin Endocrinol Metab. 2004;89:5175-5180.
49. Takano T, Miyauchi A, Matsuzuka F, et al. PGP9.5 mRNA could contribute to the molecular-based diagnosis of medullary thyroid carcinoma. Eur J Cancer. 2004;40:614-618.
50. Fuhrer D, Eszlinger M, Karger S, et al. Evaluation of insulin-like growth factor II, cyclooxygenase-2, ets-1 and thyroid-specific thyroglobulin mRNA expression in benign and malignant thyroid tumours. Eur J Endocrinol. 2005;152:785-790.
51. Furlan JC, Bedard YC, Rosen IB. Single versus sequential fine-needle aspiration biopsy in the management of thyroid nodular disease. Can J Surg. 2005;48:12-18.
52. Mitteldorf CA, Leite KR, Darini E, Carvalho CM, CamaraLopes LH. Optimal recovery of DNA for polymerase chain reaction-based assays from fine needle aspirates. A comparison of 4 preparation types. Acta Cytol. 2002;46:1117-1122.